Antitumor efficiency of sonodynamic therapy in combination with chlorine-based photosensitizer in experiments

Author:

Protopovich E. L.1ORCID,Tzerkovsky D. A.1ORCID

Affiliation:

1. N. N. Alexandrov National Cancer Center of Belarus

Abstract

Introduction. Sonodynamic therapy is a topical research area in experimental oncology. The method is based on the combined use of photosensitizing agents with ultrasonic radiation with certain parameters. The result of this interaction is the induction of sonochemical reactions and the effect of cavitation in the tumor cell. The consequence is its death (apoptosis, autophagy).The study objective is to investigate the antitumor efficacy of sonodynamic therapy with a chlorine-based photosensitizer (PS) in an experiments on laboratory animals with transplantable tumors.Materials and methods. The experimental study was performed on 50 white outbred rats weighing 250 ± 50 grams. Subcutaneously transplanted Pliss lymphosarcoma (PLS) and alveolar liver cancer RS1 (RS1) were used as tumor models. Chlorine-based PS (Belmedpreparaty, Republic Belarus) was injected intravenously at a dose of 2.5 mg / kg. The ultrasound sessions (US) were carried out 2.5–4 hours (depending on the tumor strain) after the administration of the PS using the device Phyaction U (Gymna Yniphy, Belgium) with frequencies of 1.04 and 3 MHz, intensity of 2 W / cm2 and duration of 10 minutes in continuous mode. For each of the tumor model the study was performed on 25 laboratory animals subdivided into groups of 5 individuals: intact control, US 1.04 MHz; US 3 MHz; PS + US 1.04 MHz and PS + US 3 MHz. The criteria for assessing the antitumor efficacy were indicators of the dynamics of the growth of transplanted tumors: аverage volume of tumors (Vav, cm3), the coefficient of tumor growth inhibition (TGI, %), coefficient of absolute growth of tumors (K) and the frequency of complete regressions 60 days after treatment (%).Results. For PLS Vav in groups were 32.72 ± 7.23; 26.81 ± 1.06; 14.80 ± 5.08; 9.37 ± 6.05 and 22.25 ± 4.91 cm3, respectively (p ˂0.05). The coefficients TGI in the experimental groups were 20.27; 54.77; 71.36 and 31.99 %, respectively. Indicators K in groups were 21.64; 14.52; 6.12; 4.91 and 15.34, respectively. The frequency of complete tumor regressions 60 days after the start of the experiment was 0, 20, 20, 40 and 0 %, respectively. For RS1 Vav in groups were 23.29 ± 5.11; 6.22 ± 2.22; 11.78 ± 4.57; 6.38 ± 2.57 and 13.06 ± 3.53 cm3, respectively (p ˂0.05). The coefficient of TGI in the experimental groups were 73.25; 49.42; 72.60 and 43.92 %, respectively. Indicators K in groups were: 8.34; 1.11; 3.39; 2.91 and 5.05, respectively. The frequency of complete tumor regressions 60 days after the start of the experiment was 0, 0, 0, 40 and 0 %, respectively.Conclusions. The data obtained indicate a trend towards an increase in the antitumor effectiveness of the combined use of PS and sonodynamic therapy on various histological structures and growth patterns of transplanted tumors, as well as the prospects for further studies of the sonosensitizing properties of photosensitizing agents.

Publisher

Publishing House ABV Press

Reference15 articles.

1. Tzerkovsky D.A., Protopovich E.L., Stupak D.S. Sonodynamic and sonophotodynamic therapy in oncology. Biomedical Photonics 2019;8(2):31–46. DOI: 10.24931/2413-9432-2019-8-2-31-46.

2. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy – a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004;11(6):349–63. DOI: 10.1016/j.ultsonch.2004.03.004.

3. Yumita Т., Nishigaki T., Umemura K., Umemura S.I. Synergetic effect of ultrasound and hematoporphyrin on sarcoma 180. Jpn J Cancer Res 1990;81(3):304–8. DOI: 10.1111/j.1349-7006.1990.tb02565.x.

4. Tserkovsky D.A., Alexandrova E.N., Chalau V.N., Istomin Yu.P. Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model. Exp Oncol 2012;34(4):332–5.

5. Tzerkovsky D.A., Alexandrova E.N., Chalau V.N., Istomin Yu.P. Sono-photodynamic therapy for sarcoma M1 in rats. Rossiyskiy Bioterapevticheskiy Zhurnal = Russian Journal of Biotherapy 2012;11(4):29–31. (In Russ.).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3